Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay
Kappa, Antigen, Antiserum, Control. 510(k) K220001, from Diazyme Laboratories, Inc. (Poway, CA). Product code DFH, class 2.
As of Nov 19, 2026, K220001 is an FDA 510(k) held by Diazyme Laboratories, Inc., substantially equivalent on Aug 4, 2022 after 212 days, with no recalls tied to it in FDA's recall database.
- Review time: 212 days
- Recalls: 0
The Diazyme Human Kappa Free Light Chain Assay is intended as a latex particle enhanced immunoturbidimetric assay for the quantitative determination of Kappa Free Light Chain (FLC) concentration in serum on validated analyzers.
- Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light Chain AssayK253358 · Diazyme Laboratories, Inc. · Dec 19, 2025
- Optilite® Freelite Mx Kappa Free Kit; Optilite® Freelite Mx Lambda Free KitK250549 · The Binding Site Group , Ltd. · May 23, 2025
- FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2K231601 · Sebia · Feb 23, 2024
- Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitK231290 · The Binding Site, Ltd. · Jan 24, 2024
- FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2K210623 · Sebia · Nov 18, 2022
- Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain AssayK211648 · Diazyme Laboratories, Inc. · Sep 8, 2022
- N Latex FLC kappa, N Latex FLC lambdaK212379 · Siemens Healthcare Diagnostics Products GmbH · Mar 2, 2022
- N Latex FLC kappa, N Latex FLC lambdaK201496 · Siemens Healthcare Diagnostics Products GmbH · Oct 29, 2021
- Type
- Traditional
- Received
- Jan 4, 2022
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5550
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files